Post-Conference Perspectives: Urothelial Carcinoma 2022 Year in Review - Episode 2
Srikala Sridhar, MD, MSc, FRCPC, explains the importance of neoadjuvant cisplatin-based chemotherapy and why bladder-sparing treatments should be considered for all patient populations.